Twenty one-to two-month-old Holstein, Angus, or Holstein-Angus crossbred calves were given intravenous complete Freund's adjuvant and their lungs were examined at 24 hours to 30 days post-injection. Two calves given intravenous saline served as normal controls. The evolving pulmonary inflammatory response was characterized initially by multifocal vasculitis and acute multifocal exudative pneumonitis which progressed to a granulomatous interstitial pneumonitis by seven days post-injection. Discrete granulomas characterized the lesions in the lungs and lymph nodes at 30 days post-injection, and granulomas also were seen in liver, kidney, and spleen. Clinically, the calves were tachypneic and pyrexic during the first week post-injection. Four calves developed acute pulmonary edema and died during, or shortly after, administration of the adjuvant. This model of experimental pneumonia in calves is similar to complete Freund's adjuvant-induced experimental pneumonia in other species. It is reproducible and predictable in its course of development and resolution, and provides a useful model for studying basic mechanisms of pulmonary inflammatory injury and repair in the bovine lung.
In comparison to other domestic species, cattle seem particularly susceptible to inflammatory pulmonary disease, possibly as a consequence of multiple factors including anatomic peculiarities and functional differences in pulmonary defense mechanisms [41] . In order to study the basic mechanisms involved in the development and resolution of acute inflammatory lesions in the bovine lung and their impact on pulmonary clearance mechanisms, it is necessary to utilize a uniformly reproducible, controllable and, ideally, noninfectious experimental model of pulmonary injury.
Various infectious agents including Pasteurellu sp. [ 17, 181 , parainfluenza virus type 3 [9] , infectious bovine rhinotracheitis virus [22] , and bovine respiratory syncytial virus [27] , have been used to induce experimental pneumonia in cattle and calves. The use of these agents, however, necessitates isolation facilities and special precautions in handling of animals and tissues, and the disease produced by such agents often is difficult to reproduce uniformly.
A variety of noninfectious agents including 3-methylindole [lo], L-tryptophan [ 13, 371, 4-ipomeanol [ 14, 32, 451 and the "perilla ketone" [25, 461 as well as NO2 gas [ 121 have been used experimentally to produce respiratory disease in cattle or have been incriminated in natural outbreaks of bovine pulmonary disease [7, 331 . All produce severe, diffuse alveolar damage secondary to toxic injury to alveolar or terminal bronchiolar epithelium or capillary endothelium, and result in various amounts of inflammation. The severe, diffuse nature of the toxic lung injury may result in high mortality in experimental animals.
Bovine hypersensitivity pneumonitis is another example of naturally occurring, experimentally reproducible, noninfectious pulmonary inflammatory disease in cattle. This disease is apparently the result of hypersensitivity reactions occurring in the lungs of cattle sensitized to Micropolysporu fueni antigens [34] .
The pulmonary response to intravenous complete Freund's adjuvant has been detailed in various species [5, 8, 11, 15, 16, 19, 20, 28, 29, 36, 391 . It is characterized by a pronounced acute inflammatory reaction and limited mononuclear cell infiltration of the pulmonary interstitium and meets the criteria of uniformity and reproducibility. In the rabbit, for example [8] , the inflammatory reaction is characterized by an extensive and prolonged vascular and exudative response in the lung, granuloma formation, and damage to all structural components of the alveolar septa. Despite the severity of the acute reaction, complete resolution and return to nearnormal architecture is achieved eventually.
This study was designed to define the nature of the pulmonary response to complete Freund's adjuvant in the bovine lung in order to develop a useful model for studies on the interaction of the inflammatory process and bovine pulmonary clearance mechanisms. We examined the sequential histology of the evolving pulmonary inflammatory reaction with particular attention to the nature and sequence of inflammatory cells involved and the extent of damage to various components of the pulmonary parenchyma.
Materials and Methods
Animals: Twenty-two conventionally reared Holstein, Angus or Holstein-Angus crossbred calves were obtained locally at one to six days of age and kept under observation for 30 to 60 days prior to use. The calves were fed milk replacer twice per day, allowed water and alfalfa hay ad libitum, penned individually or in pairs, and bedded on straw. Eighteen male and four female calves were used in the study. All calves were given a physical examination upon arrival and again prior to use in the experiment, and calves which had signs of respiratory disease were not used.
Experimental design: Twenty calves were given complete Freund's adjuvant (Bacto-adjuvant, Complete Freund, code 0638, Difco Labs, Detroit, Mich.) via slow jugular infusion at a dosage of 0.5 ml adjuvant/kg body weight. Injection typically required 10 to 20 minutes or longer to complete. Two calves were killed at each examination point: 24, 48, 72, 96 hours, and 7, 14, 21, or 30 days post-injection. Two calves given intravenous injections of normal saline at a dosage of 0.5 ml/kg body weight were killed at seven days post-injection.
Specimen preparation:
The calves were killed via stunning with a captive bolt and subsequent exsanguination by severing the axillary vessels. A routine necropsy was done on each calf. The lungs were isolated, weighed, immersed in 10% neutral buffered formalin and perfused with the same via the trachea at a constant pressure of 30 to 40 cm fixative. The fixative was allowed to run into the lungs until the flow stopped, then the tube was clamped and the lungs were fixed for 48 to 72 hours.
After fixation, 15 samples of lung tissue were trimmed for embedding according to a predetermined sampling procedure. Two tissue samples (one dorsal and one ventral) were taken from standardized areas of each lobe, except that only one sample was taken from the accessory lobe. Samples of trachea, left tracheobronchial lymph node, liver, kidney, and spleen also were fixed for histologic evaluation. All tissues were processed routinely and embedded in paraffin. Tissue sections were cut at 4 pm, stained with hematoxylin and eosin, and examined by light microscopy.
Results

Clinical findings
Tachypnea, shallow respiration, elevation of heart rate, mild to profuse salivation, and profound weakness occurred within minutes after the administration of complete Freund's adjuvant. Four calves developed acute pulmonary edema during the administration of the adjuvant and exhibited severe dyspnea, moist rales, frothing, and death within five minutes to 4% hours post-injection. These calves were replaced in the experimental protocol by different calves to preserve the predetermined sacrifice protocol. Calves surviving this initial attack typically remained weak and exhibited markedly elevated respiratory and pulse rates for six to 21 hours following administration. Occasional coughing was noted. Calves generally exhibited improved respiratory signs and regained strength and appetite by 24 hours post-injection. Auscultation of the lungs during the first 24 to 96 hours revealed remarkably clear lung fields. An increased intensity of normal bronchial air sounds was the most significant change noted. Localized moist rales were noted occasionally.
Respiratory rates ( fig. 1 ) and heart rates remained elevated to 60 to 80 breaths/ minute and 80 to 120 beats/minute, respectively, through the first seven days postinjection, and breaths were typically more shallow than normal during this time. Thereafter, these parameters returned almost to normal. Heart rates, although elevated, were more variable than respiratory rates.
Pyrexia was noted at about 24 hours post-injection and generally subsided by six to ten days post-injection. Rectal temperatures of pyrexic calves typically ranged between 40°C and 41.2"C ( fig. 1 ). The calves maintained a good appetite beginning about 24 hours post-injection, and were only slightly depressed for the first few days. Clinical findings for the saline-treated calves were within normal limits throughout the observation period.
Gross pathologic findings
The lungs from calves killed at all time intervals collapsed well and contained no palpable lesions except for occasional slightly firm, reddened or tan foci measuring 1 to 3 cm in greatest dimension. These most often were seen in the cranial and middle lung lobes of calves killed one to seven days post-injection, but were not restricted to these areas. Similar lesions were seen occasionally at later times. Very small (1 to 2 At 24 hours post-injection the lesions were those of a mild, acute multifocal exudative pneumonitis characterized by intra-alveolar accumulation of fibrin, neutrophils, and macrophages. Thrombosis of small vessels and alveolar septal capillaries was a prominent feature. Necrotizing suppurative vasculitis and perivasculitis often accompanied the thrombi. Small arterioles associated with terminal bronchioles (fig. 5) were affected quite often, although thrombosis of vessels not associated with bronchioles occurred occasionally. Mild intraalveolar accumulation of polymorphonuclear leukocytes and fibrin was a prominent feature of the parenchymal lesion. An increased number of neutrophils and mononuclear cells was apparent in alveolar capillaries and other vessels. Very mild alveolar septal thickening and infiltration of septa by neutrophils and macrophages were noted also. Eosinophilic leukocytes with segmented nuclei and prominent granules were seen occasionally in alveoli and within the interstitium of affected areas. Bronchioles, interlobular septa, and pleura rarely were affected, except in areas where there was extension of a lesion from the alveolar parenchyma. Exudative parenchymal lesions were seen occasionally in areas adjacent to interlobular septa, but inflammatory exudate rarely was seen within interlobular septa. Occasional clear vacuoles, presumed to be oil droplets, were noted in the lesions; however, it often was difficult to determine if they were intravascular or interstitial. Tracheobronchial lymph nodes were characterized by marked expansion and filling of subcapsular and medullary sinuses by neutrophils, macrophages, and occasional eosinophils. A few variable-sized, clear vacuoles (oil droplets) also were present in the sinuses.
At 48 hours post-injection ( fig. 6) , the lesions were similar to those described at 24 hours, with slightly more pronounced thickening of alveolar septa and a greater influx of neutrophils and macrophages into the interstitium and alveolar lumens. Tracheobronchial lymph nodes again had expanded sinuses filled with neutrophils and macrophages, and there were moderate numbers of eosinophils present in the subcapsular and medullary sinuses.
At 72 hours post-injection, the exudative nature of the lesions was very pronounced and there was eosinophilic hyaline debris ( fig. 7 ) in some alveolar spaces. Interalveolar septa were thickened markedly and distorted sometimes by the inflammatory infiltrate. Alveolar epithelial hyperplasia characterized by cuboidal cells lining thickened septa also was apparent at this time. Oil droplets were present within the focal pulmonary lesions and also in tracheobronchial lymph nodes. Primary and secondary lymphoid follicles were prominent in the tracheobronchial lymph nodes at 72 hours, and the sinuses still were expanded by neutrophils and macrophages.
At 96 hours post-injection the lesion was comparatively more severe than at 72 hours, and was characterized by a marked mononuclear interstitial infiltrate with a prominent mixture of neutrophils and many eosinophils. A similar cellular exudate was present in alveolar lumens. The vasculitis and perivasculitis was quite pronounced in small arterioles associated with terminal bronchioles similar to sites where thrombosis had been observed earlier. Vessels in these areas were completely obliterated occasionally, making vascular involvement difficult to recognize. Bronchioles, interlobular septa, and the pleura remained relatively unaffected except by local extension of parenchymal lesions. Tracheobronchial lymph nodes were similar to those described at 72 hours post-injection.
At seven days post-injection the lesion was predominantly granulomatous and characterized by multifocal mononuclear cell infiltration, thickening, and distortion of alveolar septa. There was little exudate remaining in alveoli, except in severely affected lobules. Alveolar epithelial hyperplasia was prominent on thickened alveolar septa ( fig. 8 ). Oil droplets and small to moderate numbers of neutrophils persisted in the granulomatous foci and also were seen in tracheobronchial lymph nodes. Occasional multinucleate giant cells (Langhans' type) were present in the pulmonary interstitial lesions.
At 14 days post-injection ( fig. 9 ), the lesion was distinctly granulomatous with a distribution of lesions similar to that described earlier. Moderate numbers of giant cells were present and there were occasional areas of fibrosis of thickened septa. Severely affected areas contained neutrophils, macrophages, and fibrin in alveolar trate; persistence of oil droplets within the granuloma.
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Lay and Slauson lumens, and there was marked fibrosis in some areas. Oil droplets persisted in lesions and lymph nodes. The subcapsular and medullary sinuses of the tracheobronchial lymph nodes were much less distended than they had been earlier and very few neutrophils were present. Primary and secondary lymphoid follicles still were prominent. Eosinophils were noted rarely in the lungs or lymph nodes.
At 21 and 30 days post-injection the lesions consisted of discrete epithelioid granulomas of various sizes within alveolar septa, and adjacent to small bronchioles and arterioles. Granulomas were confluent occasionally and resulted in large lesions in some areas. Alveolar septa were not as thickened, and there was little alveolar epithelial hyperplasia. Mild to moderate lymphocytic infiltrates and occasional lymphoid foci ( fig. 10) were present within and around the edges of some granulomas. Prominent focal peribronchiolar lymphoid aggregates were associated with occasional bronchioles in all lobes of both calves killed at 30 days post-injection. Oil droplets persisted in the pulmonary granulomas and lymph nodes. Tracheobronchial lymph nodes contained small focal granulomas within the cortex which were occasionally quite prominent. Few neutrophils or eosinophils remained in the pulmonary lesions or lymph nodes. Lungs from normal calves had no lesions with the exception of the right cranial lobes. Lesions in these areas were typical of subacute focal bronchopneumonia characterized by mild infiltrates of neutrophils and a few macrophages and fibrin within alveoli and bronchioles, as well as dense peribronchiolar mononuclear cell infiltrates. Lymph nodes from normal calves contained several primary and secondary follicles, but they were otherwise unremarkable. Lungs from calves which died during administration of the adjuvant were characterized by peribronchiolar and perivascular edema and lymphangiectasia, as well as alveolar and bronchiolar edema.
Liver: A mild to moderately dense inflammatory infiltrate characterized by lymphocytes, plasma cells, and a few neutrophils was apparent around scattered portal triads and occasionally clustered in sinusoids within the hepatic parenchyma by 72 hours post-injection. The lesions became slightly more severe with time, and by seven days post-injection, small discrete granulomas which occasionally contained clear oil droplets and small numbers of neutrophils were scattered in the hepatic parenchyma. Similar lesions persisted in livers at 30 days post-injection. No lesions were found in livers from normal calves.
Spleen: Spleens from calves injected with complete Freund's adjuvant were not markedly different from those of the normal calves, except that there was a very mild diffuse proliferation of mononuclear cells in the red pulp of spleens beginning about 72 hours post-injection. Occasional small focal granulomas were scattered in spleens examined at 21 and 30 days post-injection.
Kidney: Mild, small, multifocal, lymphoplasmacytic cortical interstitial infiltrates with a few neutrophils were apparent at 72 hours and persisted in calves killed 30 days post-injection, and were occasionally associated with small vessels. Scattered small discrete granulomas were present by 21 days post-injection and occasional glomeruli contained prominent clear spherical vacuoles (oil droplets) inside capillary lumens. The mesangium of some glomeruli was thickened slightly at later stages. One calf, killed at 21 days post-injection, had bilateral chronic pyelonephritis with extensive cortical interstitial fibrosis.
Trachea: Tracheae from saline-treated and adjuvant-treated calves both contained mild mucosal inflammatory infiltrates characterized by lymphocytes and a few neutrophils. No granulomas were seen.
Discussion
Intravenous infusion of complete Freund's adjuvant in calves leads to a rapidly developing pulmonary inflammatory response which is reproducible and predictable in its course of development and resolution. The lesions have a multifocal distribution, scattered throughout all lung lobes, related to the intravenous mode of delivery of adjuvant droplets to the pulmonary capillary bed. Some of the adjuvant apparently passes through the lungs to the systemic circulation and produces lesions in other organs. Pulmonary lesions usually are limited to the alveolar parenchyma, tend to spare bronchioles, interlobular septa and pleura, and are surrounded by large areas of normal pulmonary parenchyma. The earliest lesions are thrombosis and acute vasculitis associated with adjuvant emboli and physically or chemically induced endothelial damage. Vasculitis has been noted in the early stages of adjuvant-induced pneumonia in other species [8, 11, 361 . The acute exudative phase develops rapidly following endothelial damage, leakage of serum proteins, and presumably, activation of inflammatory amplification systems and chemotaxis of neutrophils. This exudative phase is essentially resolved by seven days post-injection, at which time the lesion is predominantly granulomatous. The relatively prominent infiltration of eosinophils in the lungs and lymph nodes of calves killed in the first seven days post-injection might be explained by the fact that chemotactic agents which attract neutrophils also are chemotactic for eosinophils. Eosinophils also have been reported in the acute lesions of adjuvant-induced pneumonia in rabbits [22] and rats [ 161.
The initial exudative phase is followed by multifocal mononuclear inflammatory cell infiltration of the pulmonary interstitiurn, granuloma formation, and tissue repair. The findings in this study are consistent with the light-microscopic descriptions of the pulmonary parenchymal response to complete Freund's adjuvant in other species [5, 8, 1 1, 15, 16, 20, 24, 28, 29, 36, 38, 39, 431 . The disappearance of neutrophils from the lesions may have occurred more rapidly than in other species, and no lymphoid cells were prominent in the lesions until relatively late, 21 to 30 days postinjection. Lymphoid infiltration may have been a more prominent feature if we had examined calves beyond 30 days post-injection.
A prominent feature of the pulmonary response to intravenous complete Freund's adjuvant in the rabbit is the proliferation of type-I1 pneumonocytes [8, 15, 281 . Alveolar epithelial hyperplasia was seen in bovine lungs beginning about 72 hours post-adjuvant injection. Extensive research on the renewal of alveolar epithelium following toxic lung injury [l, 6, 471 has demonstrated that proliferation of type-I1 pneumonocytes is a reparative response to replace damaged type-I pneumonocytes.
It is reasonable to presume that the proliferation of alveolar epithelium (presumably type-I1 cells) in this study is also a reparative process resulting from destruction of type-I pneumonocytes by the acute inflammatory response. Hyperplasia of alveolar epithelial cells is a common response in the reparative stages of naturally occurring bronchopneumonia or following the diffuse alveolar damage secondary to ingestion of L-tryptophan, or 3-methylindole.
Granuloma formation is a characteristic feature of the pulmonary response to intravenous complete Freund's adjuvant in the calf and other species [8, 15, 20, 28, 29, 36, 391 . In this study, granuloma formation occurred by seven days post-adjuvant injection and remained prominent for the remainder of the 30-day observation interval. It is not known whether the granulomas would have eventually regressed completely, as reported in other species [8, 15, 28, 291 . Initially, the granulomatous inflammatory response resulting from intravenous injection of complete Freund's adjuvant is apparently a nonspecific, nonimmunologic phenomenon [20, 29, 3 I] . Water in oil emulsions, such as Freund's incomplete adjuvant, tend to stimulate a macrophage response and incite a chronic inflammatory reaction [3 11 . Complete Freund's adjuvant is a mixture of paraffin oil, killed Mycobacterium butyricum, and an emulsifying agent, mannide monooleate. Experiments designed to assess the role of the various components of complete Freund's adjuvant [20] demonstrated that the paraffin oil fraction is capable of causing a transient, limited proliferation of pulmonary septa1 mononuclear cells, apparently s e c o n d a~ to phagocytosis of the oil. The oil fraction in combination with the M. butyricum fraction results in the same proliferation of mononuclear cells and progression to epithelioid granulomas. Injection of the M. butyricum fraction alone results in very small persistent granulomas. Thus, the oil and M. butyricum fractions are synergistic in their effects upon the pulmonary parenchymal response. This may in part be due to the effects of lymphokines, such as migration-inhibition factor and macrophage-activating factor, which are secreted by T lymphocytes stimulated by the M. butyricum fraction of the adjuvant.
Similarities between the adjuvant-induced pneumonitis and naturally occurring bovine pulmonary inflammatory disease exist only in a very broad sense. Though the agents which incite the inflammation differ, the basic mechanisms of tissue injury induced by inflammatory processes are probably similar in naturally occurring and experimentally induced disease. Likewise, the lung has only a limited number of ways in which it can respond to tissue damage. Major differences exist, however, between naturally occurring disease and adjuvant-induced pneumonitis. The complete Freund's adjuvant model of pulmonary inflammation spares airways and bronchiolar epithelium, interlobular septa and pleura, and has a multifocal distribution in contrast to the locally extensive distribution typical of many naturally occurring forms of bovine bronchopneumonia [23] . The initial vasculitis, and later the granuloma formation, are not typical of most bovine pneumonias with the exceptions of hypersensitivity pneumonitis [34] and tuberculosis [23] . The intravenous injection of complete Freund's adjuvant results in a sustained increase in alveolar macrophages recoverable by bronchopulmonary lavage [S, 161. We have made similar observations in bronchopulmonary lavage fluid from calves with adjuvant-induced pneumonitis (unpublished data). Possible sources of the increased alveolar macrophages include the proliferation of macrophages within the lung as well as recruitment of blood monocytes [42] . Adjuvant-stimulated macrophages are activated macrophages as assessed by increases in size, phagocytic capacity, cytoplasmic basophilia, rough endoplasmic reticulum content, ribonucleic acid content, and number of immunoglobulin Fc receptors on the cell surface [2, 5, 211 . Alveolar macrophages infected by agents such as parainfluenza-3 virus, however, are diminished in their functional capacity [35] , in contrast to the activated state of the complete Freund's adjuvant-stimulated alveolar macrophages. Pastewella hernolytica, the agent of bovine pneumonic pasteurellosis, has been shown to be cytotoxic to bovine alveolar macrophages [4, 261. Since alveolar macrophages play an important role in both specific and nonspecific pulmonary defense mechanisms, this is a significant difference between the complete Freund's adjuvant model and naturally occurring bovine pulmonary disease. This difference might be experimentally exploitable in studying the relative importance of the alveolar macrophage in clearance mechanisms active in an inflamed lung.
The acute pulmonary edema, accidentally induced during the administration of adjuvant to four of the calves, is a significant problem. Careful, slow infusion of adjuvant is critical and rapid injection tends to increase the likelihood of inducing pulmonary edema. Mixing of the adjuvant with an equal volume of saline and dividing the dose into two equal doses administered 24 hours apart results in a similar pulmonary lesion. Several calves injected by this method (not reported in this study) seemed to tolerate the injections better than if the full dose of adjuvant is administered. The acute pulmonary edema is possibly the result of the microembolism of adjuvant droplets into the pulmonary capillary bed. Such microembolism alone surely would result in nonhomogeneous obstruction of the pulmonary vasculature, reduction of pulmonary vascular cross-sectional area, and hypertension in remaining capillaries and arterioles [30, 441 . The resultant ventilation/perfusion imbalance, if severe enough, could lead to hypoxia, acidosis, and ultimately to peripheral vasoconstriction [3, 441 which would augment the already existing hypertension. If sufficient adjuvant-oil droplet emboli reached the systemic circulation and cerebral vasculature, massive a-adrenergic stimulation may occur, resulting in a form of neurogenic pulmonary edema [40] .
The intravenous injection of complete Freund's adjuvant in calves results in a reproducible, acute, multifocal, exudative pulmonary inflammatory response which progresses rapidly to a granulomatous pneumonitis. As a model of noninfectious pulmonary inflammation, it has a high degree of uniformity from animal to animal and a predictable course of development and resolution. Since it is noninfectious, problems associated with experimentation using infectious agents are avoided. This model of pulmonary inflammation may be particularly useful for the study of the relative importance of alveolar macrophages in pulmonary clearance and pulmonary defense mechanisms in inflamed bovine lungs.
